Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-02

Clinical Trial Update: CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This update covers a Phase 1 trial of a CAR-T therapy targeting carcinoembryonic antigen (CEA) for CEA-positive advanced solid tumors, currently recruiting. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEA-targeted CAR-T therapy (CAR-T cell therapy targeting carcinoembryonic antigen (CEA))

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Lung Cancer, Gastric Cancer | Phase 1 | Status: RECRUITING